Phase II trial of bortezomib plus doxorubicin in hepatocellular carcinoma (E6202): a trial of the Eastern Cooperative Oncology Group.
硼替佐米联合多柔比星治疗肝细胞癌的 II 期试验 (E6202):东部肿瘤协作组的一项试验
期刊:Investigational New Drugs
影响因子:2.7
doi:10.1007/s10637-014-0111-8
Ciombor Kristen K, Feng Yang, Benson Al Bowen 3rd, Su Yingjun, Horton Linda, Short Sarah P, Kauh John Sae Wook, Staley Charles, Mulcahy Mary, Powell Mark, Amiri Katayoun I, Richmond Ann, Berlin Jordan